This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Bioregen Biomedical (Changzhou) Co., Ltd., Nanjing Sanhome Pharmaceutical Co., Ltd.. Active years: 2015-2018.
Location History:
- Nanjing, CN (2015)
- Jiangsu, CN (2016 - 2018)
Company Filing History:
2 out of 6 
1 out of 11 Years Active: 2015-2018
Title: Yunyun Wang: Innovator in Biocompatible Macromolecule Derivatives
Introduction
Yunyun Wang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biocompatible macromolecules, focusing on innovative derivatives that enhance their functionality and application in medicine.
Latest Patents
Yunyun Wang holds 3 patents, with his latest invention being a mercapto-modified biocompatible macromolecule derivative featuring a low degree of mercapto-modification. This invention maintains the initial structure, physiological function, and biocompatibility of the macromolecule while allowing for the preparation of cross-linked materials with a low degree of cross-linking. The disulfide-bond cross-linked biocompatible macromolecule material developed by Wang effectively prolongs turnover and reduces solubility in vivo, making it suitable for various clinical applications. His work significantly contributes to advancements in the fields of medicine and pharmacy.
Career Highlights
Throughout his career, Yunyun Wang has worked with prominent companies such as Bioregen Biomedical (Changzhou) Co., Ltd. and Nanjing Sanhome Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, furthering the development of biocompatible materials.
Collaborations
Yunyun Wang has collaborated with notable colleagues, including Xiaozheng Shu and Weiping Zhong. These partnerships have fostered a collaborative environment that enhances the research and development of new biocompatible materials.
Conclusion
Yunyun Wang's contributions to the field of biocompatible macromolecule derivatives demonstrate his commitment to innovation and advancement in medical applications. His patents and collaborations reflect a dedication to improving healthcare through scientific research.